Revolutionising IVF: The promise of personalised medicine in Bengaluru

NT Correspondent Bengaluru: The landscape of medicine is continually evolving, leading to the rise of personalised treatment plans tailored to individual patient needs. One area where this is particularly transformative is in vitro fertilisation (IVF), a form of Assisted Reproductive Technology (ART). Recent advancements have shown that incorporating personalised medicine into IVF can significantly enhance success rates while alleviating emotional and financial burdens for couples seeking to conceive. Experts agree that personalised IVF offers hope to many who face challenges in natural conception.

Dr Rashmi Yogish, Clinical Director at Khushi Fertility and IVF Centre, emphasises the uniqueness of each couple's journey to parenthood. She notes that conventional IVF methods, while beneficial, often overlook specific genetic, lifestyle and environmental factors influencing fertility. Personalised IVF allows practitioners to tailor treatments that address these nuances, leading to improved outcomes. By adjusting hormone therapies and utilising advanced genetic testing for embryo selection, IVF can now offer a level of precision that was previously unattainable. Dr. Yogish reports heartwarming successes where couples, once disheartened by infertility, are now celebrating new births. Similarly, Dr Prakrutha S, Consultant in Fertility and Reproductive Medicine at Aster CMI Hospital, highlights how personalised medicine harnesses genetic and environmental data to refine treatment plans.

This approach includes optimising gonadotropin dosages using AI-driven ultrasound technology and developing predictive models based on advanced data from embryo cultures. Moreover, by investigating male infertility through seminal plasma proteomics, doctors can better identify underlying causes, enhancing treatment strategies. Personalised medicine also aims to standardise treatments, minimise risks of multiple pregnancies and address recurrent IVF failures, thus improving the overall success rates of single embryo transfers. Dr Santosh Bhargav D B, Co-founder and Director-CTO of SpOvum Technologies, observes that India is becoming a frontrunner in personalised IVF by integrating advanced reproductive technologies. AI and big data analytics are revolutionising diagnostic accuracy and treatment customisation.

AI algorithms analyse extensive patient data to predict the most effective IVF strategies, significantly enhancing embryo selection and reducing the likelihood of failed cycles. Recent studies indicate that personalised IVF protocols can improve success rates by 20-30 per cent compared to conventional methods. The future of personalised medicine in IVF is bright, particularly in India, where technological advancements are reshaping reproductive health. By focusing on individual needs and utilising cutting-edge technology, fertility specialists are paving the way for more success.